Interrater reliability for histopathologic diagnosis of keratinocyte carcinomas - 13/12/17
Doi : 10.1016/j.jaad.2017.07.024
Nicholas F. Leader, MS a, b, c, ⁎ 
, Alexander D. Means, MD a, b, Leslie Robinson-Bostom, MD a, b, Gladys H. Telang, MD a, Caroline S. Wilkel, MD a, Martin A. Weinstock, MD, PhD a, b
for the
, Alexander D. Means, MD a, b, Leslie Robinson-Bostom, MD a, b, Gladys H. Telang, MD a, Caroline S. Wilkel, MD a, Martin A. Weinstock, MD, PhD a, bfor the
Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial group
a Department of Dermatology, Alpert Medical School of Brown University, Providence, Rhode Island
b Center for Dermatoepidemiology, Veterans Affairs Medical Center, Providence, Rhode Island
c Chicago Medical School at Rosalind Franklin University of Medicine and Science, North Chicago, Illinois
∗Correspondence to: Nicholas F. Leader, MS, Center for Dermatoepidemiology, Providence VA Medical Center, 830 Chalkstone Ave, Providence, RI 02908-4799Center for DermatoepidemiologyProvidence VA Medical Center830 Chalkstone AveProvidenceRI02908-4799
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
© 2017
Publié par Elsevier Masson SAS.
Vol 78 - N° 1
P. 185-187 - janvier 2018 Retour au numéro
Article précédent
- Metastatic melanoma after solid organ transplantation: An interdisciplinary, institution-based review of management with systemic and targeted therapies
- Shivani V. Tripathi, Caroline R. Morris, Tarek Alhamad, Ryan C. Fields, Gerald P. Linette, Lynn A. Cornelius
- Trends in US sunscreen formulations: Impact of increasing spray usage
- Rebeca W. Teplitz, Alex M. Glazer, Ryan M. Svoboda, Darrell S. Rigel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?